Continuous renal replacement therapy reduces the systemic and pulmonary inflammation induced by venovenous extracorporeal membrane oxygenation in a porcine model

Artificial Organs

Volumn 38, Issue 3, 2014, Pages 215-223

  Shi, Jialiang ^a   Chen, Qiyi ^a   Yu, Wenkui ^a   Shen, Juanhong ^a   Gong, Jianfeng ^a   He, Changsheng ^a   Hu, Yiming ^a   Zhang, Juanjuan ^a   Gao, Tao ^a   Xi, Fengchan ^a   Li, Jieshou ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Continuous renal replacement therapy; Cytokine; Electron microscopy; Extracorporeal membrane oxygenation; Histopathology; Lung

Indexed keywords

BLOOD; CARBON DIOXIDE; GENE EXPRESSION; GRADING; OXYGENATION; RESPIRATORY THERAPY;

AIR BARRIERS; CANNULATIONS; CONTINUOUS RENAL REPLACEMENT THERAPY; CYTOKINES; EXTRACORPOREAL MEMBRANE OXYGENATION; HISTOPATHOLOGY; INTERLEUKIN6 (IL6); PORCINE MODELS; RENAL REPLACEMENT THERAPIES; TUMOR NECROSIS FACTORS;

BIOLOGICAL ORGANS;

INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

AIR CONDITIONING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL CARBON DIOXIDE TENSION; ARTICLE; BLOOD GAS ANALYSIS; CANNULATION; CONTINUOUS RENAL REPLACEMENT THERAPY; CONTROLLED STUDY; CYTOKINE RELEASE; EXPERIMENTAL PIG; EXTRACORPOREAL MEMBRANE OXYGENATION DEVICE; EXTRACORPOREAL OXYGENATION; FEMALE; GENE EXPRESSION; HEART RATE; HISTOPATHOLOGY; LUNG GAS EXCHANGE; LUNG HEMODYNAMICS; LUNG LAVAGE; LUNG PARENCHYMA; MALE; NONHUMAN; OXYGENATION; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM; TIDAL VOLUME; VENOVENOUS EXTRACORPOREAL MEMBRANE OXYGENATION;

SUIDAE; SUS;

CONTINUOUS RENAL REPLACEMENT THERAPY; CYTOKINE; ELECTRON MICROSCOPY; EXTRACORPOREAL MEMBRANE OXYGENATION; HISTOPATHOLOGY; LUNG;

ANIMALS; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HEMODYNAMICS; INTERLEUKIN-6; LUNG; MALE; PNEUMONIA; RENAL REPLACEMENT THERAPY; SWINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84896721694     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/aor.12154     Document Type: Article

References (30)

1. Brogan TV, Thiagarajan RR, Rycus PT, Bartlett RH, Bratton SL. Extracorporeal membrane oxygenation in adults with severe respiratory failure: a multi-center database. Intensive Care Med 2009;35:2105-2114.
2. Cengiz P, Seidel K, Rycus PT, Brogan TV, Roberts JS. Central nervous system complications during pediatric extracorporeal life support: incidence and risk factors. Crit Care Med 2005;33:2817-2824.
3. Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009;374:1351-1363.
4. Hemmila MR, Rowe SA, Boules TN, et al. Extracorporeal life support for severe acute respiratory distress syndrome in adults. Ann Surg 2004;240:595-605; discussion 605-7.
5. Brown JK, Haft JW, Bartlett RH, Hirschl RB. Acute lung injury and acute respiratory distress syndrome: extracorporeal life support and liquid ventilation for severe acute respiratory distress syndrome in adults. Semin Respir Crit Care Med 2006;27:416-425.
6. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000;342:1301-1308.
7. Terragni PP, Rosboch G, Tealdi A, et al. Tidal hyperinflation during low tidal volume ventilation in acute respiratory distress syndrome. Am J Respir Crit Care Med 2007;175:160-166.
8. Hager DN, Krishnan JA, Hayden DL, Brower RG. Tidal volume reduction in patients with acute lung injury when plateau pressures are not high. Am J Respir Crit Care Med 2005;172:1241-1245.
9. Terragni PP, Del Sorbo L, Mascia L, et al. Tidal volume lower than 6ml/kg enhances lung protection: role of extracorporeal carbon dioxide removal. Anesthesiology 2009;111:826-835.
10. McILwain RB, Timpa JG, Kurundkar AR, et al. Plasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of preformed stores in the intestine. Lab Invest 2010;90:128-139.
11. Song J, Palmer K, Sun B. Effects of inhaled nitric oxide and surfactant with extracorporeal life support in recovery phase of septic acute lung injury in piglets. Pulm Pharmacol Ther 2010;23:78-87.
12. Fortenberry JD, Bhardwaj V, Niemer P, Cornish JD, Wright JA, Bland L. Neutrophil and cytokine activation with neonatal extracorporeal membrane oxygenation. J Pediatr 1996;128:670-678.
13. Graulich J, Walzog B, Marcinkowski M, et al. Leukocyte and endothelial activation in a laboratory model of extracorporeal membrane oxygenation (ECMO). Pediatr Res 2000;48:679-684.
14. Kurundkar AR, Killingsworth CR, McIlwain RB, et al. Extracorporeal membrane oxygenation causes loss of intestinal epithelial barrier in the newborn piglet. Pediatr Res 2010;68:128-133.
15. Mu TS, Palmer EG, Batts SG, Lentz-Kapua SL, Uyehara-Lock JH, Uyehara CF. Continuous renal replacement therapy to reduce inflammation in a piglet hemorrhage-reperfusion extracorporeal membrane oxygenation model. Pediatr Res 2012;72:249-255.
16. Protti A, Cressoni M, Santini A, et al. Lung stress and strain during mechanical ventilation: any safe threshold? Am J Respir Crit Care Med 2011;183:1354-1362.
17. Tsuno K, Miura K, Takeya M, Kolobow T, Morioka T. Histopathologic pulmonary changes from mechanical ventilation at high peak airway pressures. Am Rev Respir Dis 1991;143:1115-1120.
18. Martin C, Boisson C, Haccoun M, Thomachot L, Mege JL. Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma. Crit Care Med 1997;25:1813-1819.
19. Meduri GU, Headley S, Kohler G, et al. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 1995;107:1062-1073.
20. Mildner RJ, Taub N, Vyas JR, et al. Cytokine imbalance in infants receiving extracorporeal membrane oxygenation for respiratory failure. Biol Neonate 2005;88:321-327.
21. Heering P, Morgera S, Schmitz FJ, et al. Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med 1997;23:288-296.
22. Journois D, Israel-Biet D, Pouard P, et al. High-volume, zero-balanced hemofiltration to reduce delayed inflammatory response to cardiopulmonary bypass in children. Anesthesiology 1996;85:965-976.
23. Hoffmann JN, Hartl WH, Deppisch R, Faist E, Jochum M, Inthorn D. Hemofiltration in human sepsis: evidence for elimination of immunomodulatory substances. Kidney Int 1995;48:1563-1570.
24. Li W, Yan X, Wang H, et al. Effects of continuous high-volume hemofiltration on experimental severe acute pancreatitis in pigs. Pancreas 2007;34:112-119.
25. Friedrich JO, Wald R, Bagshaw SM, Burns KE, Adhikari NK. Hemofiltration compared to hemodialysis for acute kidney injury: systematic review and meta-analysis. Crit Care 2012;16:R146.
26. Santarpino G, Caroleo S, Onorati F, et al. Inflammatory response after cardiopulmonary bypass: a randomized comparison between conventional hemofiltration and steroids. J Cardiovasc Surg (Torino) 2009;50:555-564.
27. Brophy PD, Mottes TA, Kudelka TL, et al. AN-69 membrane reactions are pH-dependent and preventable. Am J Kidney Dis 2001;38:173-178.
28. Hoover NG, Heard M, Reid C, et al. Enhanced fluid management with continuous venovenous hemofiltration in pediatric respiratory failure patients receiving extracorporeal membrane oxygenation support. Intensive Care Med 2008;34:2241-2247.
29. De Vriese AS, Vanholder RC, Pascual M, Lameire NH, Colardyn FA. Can inflammatory cytokines be removed efficiently by continuous renal replacement therapies? Intensive Care Med 1999;25:903-910.
30. Meltzer EC, Fins JJ. Extracorporeal membrane oxygenation for ARDS in adults. N Engl J Med 2012;366:575-576; author reply 576.